Vivos Inc (RDGL)

[SC8]

Please, we're talking about hypothetical neoadjuvant and/or adjuvant therapy before and after Radiogel treatment to maximize odds of success. Purpose of those treatments is to attack unseen and undetected microscopic cancers away from the primary tumor, as it is well known such metastases are stimulated to grow upon death of primary tumor. Radiogel treatment will have no impact on dose or duration of such neoadjuvant and/or adjuvant therapy, hence why safety comparisons to other cancer treatments are irrelevant.

Moreover, even if such safety claims were relevant, there needs to be data to substantiate such claims. To date RDGL hasn't conducted any such controlled comparisons, hence why MK comes off as an idiot when he spouts off such nonsense at FDA meetings.